VectivBio : IRONWOOD PHARMACEUTICALS, INC - Form 6-K

IRONWOOD PHARMACEUTICALS, INC.


and


VECTIVBIO HOLDING AG


Dated as of May 21, 2023




TABLE... | May 23, 2023

Related Keywords

United States ,Switzerland ,Delaware ,Bishopsgate ,United Kingdom General ,United Kingdom ,London ,City Of ,California ,Brazil ,Basel Stadt ,Boston ,Massachusetts ,New York ,State Of Delaware ,Brazilian ,Swiss ,Pricewaterhousecoopers Pw ,Brandon Fenn ,Ian Nussbaum ,Scott Applebaum ,Luca Santarelli ,Daniele Rees ,Claudia Daugusta ,Andrew Clark ,Charlesk Ruck ,John Minardo ,Michal Berkner ,Tom Mccourt ,Latham Watkins ,Company Stock Options ,None Of The Owned Company Intellectual Property ,Company Board Recommendation ,Company Material Adverse Effect ,Stock Exchange Delisting ,Company Board ,Health Care ,Exchange Act ,Drug Administration ,International Conference On Harmonization Guideline ,Company Product ,Company Restricted Share Purchase Agreements ,Company Insurance ,International Accounting Standards Board ,Exchange Commission ,Board Of Directors The Company ,Ironwood Pharmaceuticals Gmb ,Company Or Parent ,Company Shareholder Meeting ,Electronic Communications Amendments ,Public Health Service ,Exchange Act Of The ,Company Articles ,Kreos Capital Vi Expert Fund ,No Third Party Beneficiaries ,Award Or Company Restricted Share ,Vectivbio Holding ,Company Of The Transaction Agreement ,Number Of Company ,No Subsidiary Of The Company ,Good Laboratory Practice ,Electronic Communications Directive ,Company To Parent ,Government Services Administration System For Award Management ,Company Plan Under Section ,Company Disclosure Letter ,Vectivbio Us Inc ,Kreos Capital Vi United Kingdom ,Company Of The ,United States Federal Trade Commission ,World Health Organization ,Cooley United Kingdom ,Service Provider ,Service Providers ,Nasdaq Stock Market ,European Medicines Agency ,Treatment Of Company Equity Award ,Company Equity Award ,No Presumption Against Drafting Party ,Representative Of The Company ,Revenue Service ,Company Registered ,Swiss Federal Tax Administration ,Tcompany Equity ,Company Intellectual Property Or Non ,Deloitte ,Employee Share Purchase Program ,Governmental Authority ,Company Stock Plan ,Health Insurance Portability ,Company Insurance Policies ,Company Restricted Share Purchase Agreement ,Company Stock ,None Of The Company ,Nasdaq ,National Labor Relations Board ,Course Of Business The Company ,Services Providers ,Party Beneficiaries ,Affiliate Of The Company ,United Nations ,Company Permit Or Law ,United States Department Of Justice ,World Bank ,Representatives Of The Company ,Company Plan ,Party Transactions ,Company Shareholder Approval ,Company Stock Options Or ,Good Laboratory Practices ,Company Shareholders ,Neither The Company ,Ironwood Pharmaceuticals Inc ,International Monetary Fund ,Neither The Company Board ,Securities Exchange ,Centers For Disease ,European Union Or Her Majesty Treasury ,Company Restricted ,Company Stock Option Or ,Health Care Program ,Company Subsidiaries ,Company Systems ,Payment Fund ,Company Restricted Share ,Third Party Beneficiaries ,Company Registered Intellectual Property ,Company Equity Awards Or ,International Financial Reporting Standards ,Company Actions ,Treatment Of Company Equity ,Subsidiary Of The Company ,Exchange Act The ,Swiss Taxing Authority ,Cantonal Tax Administration Of Basel Stadt ,Company Of The Termination Fee ,Company Intellectual Property ,No Owned Company Intellectual Property ,Compensation Committee Of The Company Board ,Company Equity Awards ,Vote Required ,Financial Statements ,Certain Changes ,Regulatory Matters ,Financial Advisor ,Shareholder Approval Invitation ,Shareholder Meeting ,Governmental Approvals ,Certain Matters ,Exchange Delisting ,Jury Trial ,Support Agreement ,Untrue Statements ,Material Facts ,Illegal Gratuities ,Ironwood Pharmaceuticals ,Ironwood Pharmaceuticals Gmbh ,Merger Sub ,Excluded Shares ,Acceptance Time ,Offer Price ,Articles Amendment ,Board Modification ,Nasdaq Rules ,Securities Exchange Act ,Minimum Condition ,Offer Condition ,Antitrust Condition ,Offer Conditions ,Expiration Date ,Nasdaq Global Market ,Offer Documents ,Recommendation Statement ,Information Statement ,Business Days ,Compensation Committee ,Swiss Law ,Company Stock Option ,Company Restricted Shares ,Company Warrant ,Company Warrants ,Company Stock Plans ,Internal Revenue Code ,Paying Agent ,Option Consideration ,Warrant Consideration ,Governmental Entity ,Withholding Agent ,Internal Revenue Service ,Material Adverse Effect ,Material Adverse ,Annual Company Shareholder Approval ,Existing Credit Agreements ,Restricted Shares ,Measurement Date ,Stock Options ,Existing Credit ,All Company Equity Awards ,Company Shareholder ,Hart Scott Rodino Antitrust Improvements Act ,Securities Act ,Sarbanes Oxley Act ,Regulations K ,Annual Report ,Ordinary Course ,Governmental Entities ,Restricted Share Purchase Agreement ,Company Plans ,United States Law ,Each Company Plan ,Fair Labor Standards Act ,Worker Adjustment ,Retraining Notification Act ,Environmental Laws ,Environmental Law ,Leased Real Property ,Hazardous Materials ,Material Contracts ,Tax Returns ,Tax Return ,Treasury Regulations Section ,Treasury Regulation ,United States Treasury Regulations Section ,Current Report ,Top Supplier ,Each Material Contract ,Material Contract ,Company Insurance Policy ,Intellectual Property ,Non Owned Company Intellectual Property ,Owned Company Intellectual Property ,Permitted Liens ,Company Intellectual ,Subsidiarie Products ,Healthcare Laws ,Company Permits ,Company Permit ,Good Clinical Practice ,Review Board ,Good Manufacturing ,Collaboration Partner ,Corrupt Practices Act ,Combating Bribery ,Foreign Public Officials ,International Business Transactions ,United Kingdom Bribery Act ,Anti Corruption Laws ,Federal Health Care Program ,Government Services Administration ,Award Management ,Federal Health Care Program Related ,United States Department ,Foreign Assets Control ,Her Majesty ,United States Governmental Entity ,European Union ,Processing Personal Information ,Privacy Laws ,Personal Information ,All Personal Information ,Updata Partners ,Privacy Requirements ,Privacy Policy ,Data Partner ,Processed Personal Information ,Security Incidents ,Security Incident ,Personal Information Processed ,Centerview Partners ,Affiliate Transaction ,Disclosure Letter ,Parent Disclosure Letter ,Parent Material Adverse ,Nasdaq Global Select Market ,Foreign Antitrust Laws ,Shareholder Approval ,Adverse Recommendation Change ,Shareholder Approval Information ,Legal Proceeding ,Collaboration Partners ,Antitrust Law ,Annual Company Shareholder Meeting ,Swiss Stamp Duties Act ,Acquisition Proposal ,Acquisition Transaction ,Acceptable Confidentiality Agreement ,Superior Proposal ,Confidentiality Agreement ,Alternative Acquisition Agreement ,Business Day ,Termination Fee ,Regulationm A ,Non Disclosure Agreement ,Foreign Antitrust Law ,Antitrust Laws ,Counsel Only Material ,Second Request ,Non Required Remedy ,Takeover Law ,Continuing Employee ,Continuing Employees ,Existing Credit Agreement ,Warrant Agreements ,Pre Closing Holders ,Swiss Tax ,Swiss Tax Rulings ,Swiss Tax Ruling ,Swiss Taxing Authorities ,Reserves Tax ,Swiss Withholding Tax ,Outside Date ,Parent Material Adverse Effect ,Entire Agreement ,Governing Law ,Specific Performance ,Willful Breach ,Reverse Termination Fee ,Reimbursable Expenses ,Wall Street Journal ,Chief Legal Officer ,Corporate Secretary ,Swiss Official Gazette ,Sherman Act ,Clayton Antitrust Act ,Federal Trade Commission Act ,Commercial Register ,Coronavirus Aid ,Economic Security Act ,Share Purchase Program ,Restricted Share Purchase ,Restricted Share Purchase Agreements ,Incentive Plan ,Company Shares ,Disease Control ,Employee Retirement Income Security Act ,Term Loan Agreement ,Kreos United Kingdom ,Convertible Loan Agreement ,Amendment Deed ,United States Food ,Federal Food ,Cosmetic Act ,Review Boards ,International Conference ,Anti Kickback Statute ,False Claims Act ,United States Code ,Social Security Act ,Medicare Prescription Drug ,Modernization Act ,Open Payments ,Off The Shelf Software ,Uniform Trade Secrets Act ,Kreos Capital ,Expert Fund ,Owned Company Intellectual ,Patent Cooperation Treaty ,Treasury Regulation Section ,Public Health Service Act ,European General Data Protection Regulation ,United Kingdom Data Protection Act ,United Kingdom General Data Protection Regulation ,Data Protection ,Electronic Communications ,Brazilian General Data Protection Law ,Lei Geral De Prote ,Accountability Act ,Telephone Consumer Protection Act ,Consumer Fraud ,Abuse Prevention Act ,Non Solicited Pornography ,Marketing Act ,Online Privacy Protection Act ,California Consumer Privacy Act ,California Privacy Rights Act ,Swiss Code ,Swiss Federal Act ,Cantonal Tax Administration ,Swiss Federal Tax Act ,Withholding Tax ,Stamp Duties ,Warrant Agreement ,Second Warrant Agreement ,Hall Exhibits ,Support Agreements ,Presumption Against Drafting ,Chief Executive Officer ,Claudiad Augusta ,Chief Financial Officer ,Transaction Agreement ,New Shares ,Subject Shares ,Each Stockholder ,Such Stockholder ,Subject Shares Transferred ,Transfer Subject Shares ,Agreement Until ,Obligation Several ,Vectivbio Holding Ag Stock Exchange ,News ,Information ,Press Release ,Ironwood ,Vectivbio ,Molding ,Rated ,Us ,F ,Ay Vect Ch1109007893 ,